Trials / Completed
CompletedNCT03018691
Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Trial to Assess the Safety and Efficacy of 0.3% and 1% OPA-15406 Ointments When Administered for 4 Weeks in Pediatric Patients With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 2 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety, efficacy (dose response) and pharmacokinetics of 0.3% and 1% OPA-15406 when applied twice daily for 4 weeks in pediatric patients with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPA-15406 | |
| DRUG | Placebos |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2017-01-12
- Last updated
- 2020-07-23
- Results posted
- 2020-07-23
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03018691. Inclusion in this directory is not an endorsement.